Highlights

[VERSATL] YoY Annualized Quarter Result on 2016-09-30 [#2]

Stock [VERSATL]: VERSATILE CREATIVE BHD
Announcement Date 24-Nov-2016
Admission Sponsor -
Sponsor -
Financial Year 31-Mar-2017
Quarter 30-Sep-2016  [#2]
Profit Trend QoQ -     2.35%    YoY -     11.28%
Quarter Report


View:


Show?  YoY % Horiz. %

Annualized Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 51,208 57,828 53,160 46,580 44,704 52,308 0 -
  YoY % -11.45% 8.78% 14.13% 4.20% -14.54% 0.00% -
  Horiz. % 97.90% 110.55% 101.63% 89.05% 85.46% 100.00% -
PBT -2,802 -13,214 240 -3,242 -3,654 -7,878 0 -
  YoY % 78.80% -5,605.83% 107.40% 11.28% 53.62% 0.00% -
  Horiz. % 35.57% 167.73% -3.05% 41.15% 46.38% 100.00% -
Tax 0 0 0 0 7,308 0 0 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 0.00% 0.00% 0.00% 0.00% 100.00% - -
NP -2,802 -13,214 240 -3,242 3,654 -7,878 0 -
  YoY % 78.80% -5,605.83% 107.40% -188.72% 146.38% 0.00% -
  Horiz. % 35.57% 167.73% -3.05% 41.15% -46.38% 100.00% -
NP to SH -2,802 -13,214 240 -3,242 -3,654 -7,878 0 -
  YoY % 78.80% -5,605.83% 107.40% 11.28% 53.62% 0.00% -
  Horiz. % 35.57% 167.73% -3.05% 41.15% 46.38% 100.00% -
Tax Rate - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Total Cost 54,010 71,042 52,920 49,822 41,050 60,186 0 -
  YoY % -23.97% 34.24% 6.22% 21.37% -31.79% 0.00% -
  Horiz. % 89.74% 118.04% 87.93% 82.78% 68.21% 100.00% -
Net Worth 45,433 51,628 58,669 43,415 51,629 78,558 70,048 -6.96%
  YoY % -12.00% -12.00% 35.14% -15.91% -34.28% 12.15% -
  Horiz. % 64.86% 73.70% 83.76% 61.98% 73.70% 112.15% 100.00%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div - - - - - - - -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Div Payout % - % - % - % - % - % - % - % -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 45,433 51,628 58,669 43,415 51,629 78,558 70,048 -6.96%
  YoY % -12.00% -12.00% 35.14% -15.91% -34.28% 12.15% -
  Horiz. % 64.86% 73.70% 83.76% 61.98% 73.70% 112.15% 100.00%
NOSH 141,979 129,072 117,338 117,338 117,338 110,646 111,188 4.16%
  YoY % 10.00% 10.00% 0.00% 0.00% 6.05% -0.49% -
  Horiz. % 127.69% 116.08% 105.53% 105.53% 105.53% 99.51% 100.00%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -5.47 % -22.85 % 0.45 % -6.96 % 8.17 % -15.06 % - % -
  YoY % 76.06% -5,177.78% 106.47% -185.19% 154.25% 0.00% -
  Horiz. % 36.32% 151.73% -2.99% 46.22% -54.25% 100.00% -
ROE -6.17 % -25.59 % 0.41 % -7.47 % -7.08 % -10.03 % - % -
  YoY % 75.89% -6,341.46% 105.49% -5.51% 29.41% 0.00% -
  Horiz. % 61.52% 255.13% -4.09% 74.48% 70.59% 100.00% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 36.07 44.80 45.30 39.70 38.10 47.28 - -
  YoY % -19.49% -1.10% 14.11% 4.20% -19.42% 0.00% -
  Horiz. % 76.29% 94.75% 95.81% 83.97% 80.58% 100.00% -
EPS -2.00 -10.24 0.20 -2.76 -3.12 -7.12 0.00 -
  YoY % 80.47% -5,220.00% 107.25% 11.54% 56.18% 0.00% -
  Horiz. % 28.09% 143.82% -2.81% 38.76% 43.82% 100.00% -
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.3200 0.4000 0.5000 0.3700 0.4400 0.7100 0.6300 -10.67%
  YoY % -20.00% -20.00% 35.14% -15.91% -38.03% 12.70% -
  Horiz. % 50.79% 63.49% 79.37% 58.73% 69.84% 112.70% 100.00%
Adjusted Per Share Value based on latest NOSH - 254,635
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 20.11 22.71 20.88 18.29 17.56 20.54 - -
  YoY % -11.45% 8.76% 14.16% 4.16% -14.51% 0.00% -
  Horiz. % 97.91% 110.56% 101.66% 89.05% 85.49% 100.00% -
EPS -1.10 -5.19 0.09 -1.27 -1.43 -3.09 0.00 -
  YoY % 78.81% -5,866.67% 107.09% 11.19% 53.72% 0.00% -
  Horiz. % 35.60% 167.96% -2.91% 41.10% 46.28% 100.00% -
DPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
NAPS 0.1784 0.2028 0.2304 0.1705 0.2028 0.3085 0.2751 -6.96%
  YoY % -12.03% -11.98% 35.13% -15.93% -34.26% 12.14% -
  Horiz. % 64.85% 73.72% 83.75% 61.98% 73.72% 112.14% 100.00%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 0.2800 0.6900 0.7200 1.1900 0.7000 0.5700 0.4550 -
P/RPS 0.78 1.54 1.59 3.00 1.84 1.21 0.00 -
  YoY % -49.35% -3.14% -47.00% 63.04% 52.07% 0.00% -
  Horiz. % 64.46% 127.27% 131.40% 247.93% 152.07% 100.00% -
P/EPS -14.19 -6.74 352.02 -43.07 -22.48 -8.01 0.00 -
  YoY % -110.53% -101.91% 917.32% -91.59% -180.65% 0.00% -
  Horiz. % 177.15% 84.14% -4,394.76% 537.70% 280.65% 100.00% -
EY -7.05 -14.84 0.28 -2.32 -4.45 -12.49 0.00 -
  YoY % 52.49% -5,400.00% 112.07% 47.87% 64.37% 0.00% -
  Horiz. % 56.45% 118.82% -2.24% 18.57% 35.63% 100.00% -
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.88 1.73 1.44 3.22 1.59 0.80 0.72 3.40%
  YoY % -49.13% 20.14% -55.28% 102.52% 98.75% 11.11% -
  Horiz. % 122.22% 240.28% 200.00% 447.22% 220.83% 111.11% 100.00%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 27/11/19 22/11/18 21/11/17 24/11/16 27/11/15 27/11/14 28/11/13 -
Price 0.2800 0.4700 0.9300 1.3600 0.7300 0.8800 0.4950 -
P/RPS 0.78 1.05 2.05 3.43 1.92 1.86 0.00 -
  YoY % -25.71% -48.78% -40.23% 78.65% 3.23% 0.00% -
  Horiz. % 41.94% 56.45% 110.22% 184.41% 103.23% 100.00% -
P/EPS -14.19 -4.59 454.69 -49.22 -23.44 -12.36 0.00 -
  YoY % -209.15% -101.01% 1,023.79% -109.98% -89.64% 0.00% -
  Horiz. % 114.81% 37.14% -3,678.72% 398.22% 189.64% 100.00% -
EY -7.05 -21.78 0.22 -2.03 -4.27 -8.09 0.00 -
  YoY % 67.63% -10,000.00% 110.84% 52.46% 47.22% 0.00% -
  Horiz. % 87.14% 269.22% -2.72% 25.09% 52.78% 100.00% -
DY 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
  YoY % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % - - - - - - -
P/NAPS 0.88 1.18 1.86 3.68 1.66 1.24 0.79 1.81%
  YoY % -25.42% -36.56% -49.46% 121.69% 33.87% 56.96% -
  Horiz. % 111.39% 149.37% 235.44% 465.82% 210.13% 156.96% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
View candlestick stock charts with Technical indicators
MQ Affiliate
Be rewarded by being an MQ Affiliate
 
 

204  453  568  1226 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 VC 0.05-0.005 
 AT 0.090.00 
 KSTAR 0.44+0.07 
 MAHSING 0.99-0.01 
 DATAPRP 0.20-0.02 
 DGSB 0.22+0.005 
 SUPERMX 9.74-0.04 
 VIVOCOM 0.05+0.005 
 SUPERMX-C1I 0.1550.00 
 LUSTER 0.170.00 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
2. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
3. Najib Facebook Post comments on GLOVES. What's the message? gloveharicut
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
6. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
7. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
8. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
PARTNERS & BROKERS